Latest Proprietary Technology News

Orbital Corporation reveals a strategic pivot amid evolving US drone policies, with a new management team driving growth beyond Boeing Insitu. FY25 guidance shows revenue decline but promising new contracts.

COSOL Limited reported a robust 15% revenue increase in FY25, bolstered by organic growth and the strategic acquisition of Toustone, enhancing its AI capabilities. The company is poised for continued expansion with a focus on multi-year contracts and proprietary software solutions.

dorsaVi Ltd has unveiled Artemis Labs, a new subsidiary focused on developing advanced AI, sensor, and robotics technologies powered by cutting-edge RRAM. This initiative aims to transform human movement data into intelligent robotic and healthcare applications.

Argent BioPharma has signed a binding term sheet to acquire key assets from AusCann Group Holdings, significantly expanding its clinical pipeline, intellectual property, and European manufacturing and distribution capabilities ahead of a planned US stock exchange listing.

Swift Networks launches Swift TV, a Google-certified connected TV platform featuring a plug-and-play device and pre-loaded Netflix app, aiming to transform commercial entertainment spaces.

EcoGraf Limited has been granted its first Australian patent for its innovative HFfree® purification technology, reinforcing its position in the battery anode materials market. This milestone follows a recent breakthrough that cut purification costs by 25%, boosting the commercial potential of its purification facilities.

AnteoTech Ltd has received a $2.59 million cash rebate from the Australian Tax Office for its 2025 R&D activities, underscoring the success of its recent strategic initiatives.

EOS has landed a landmark €71.4 million export contract for its 100kW High Energy Laser Weapon system, marking a significant advance in counter-drone defense technology amid escalating global drone warfare threats.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

Thrive Tribe Technologies reports early commercial traction with its new digital services model, alongside a completed 20 – 1 capital consolidation and ongoing funding initiatives.

Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global growth ambitions, while targeting an additional USD 6 million from strategic investors and unlocking AUD 3 million in R&D grants.

X2M Connect reports improved revenue trends and a strengthened balance sheet after securing $5.5 million in new contracts, positioning the company for growth in FY26. A recent capital raise aims to reduce debt and fund expansion in key markets.